Mister Spex (MRX) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Aug, 2026Executive summary
Adjusted EBITDA rose 65% year-over-year to €3.8 million in H1 2026, with gross margin up 197 bps to 56.9%, despite a 10% revenue decline to €87.9 million, mainly due to weak market conditions and online shop closures.
Offline revenue grew 10% to €35.1 million, supported by store acquisitions and like-for-like growth, while online revenue declined 20–21% due to efficiency measures and shop closures.
Strategic initiatives included outsourcing logistics and production, launching B2B2C partnerships, introducing Mister Spex Kids, and implementing a unified payment platform with Adyen.
Net loss widened to €13.6 million in H1 2026, reflecting restructuring and impairment costs related to the Berlin-Spandau site closure.
Financial highlights
Q2 2026 net revenue: €47.1 million, down 11% year-over-year, with adjusted EBITDA at €2.6 million (up 55%), and gross margin at 55.4% (+162 bps YoY).
Cash and cash equivalents at quarter-end: €43.2 million, down €13.0 million from year-end 2025.
Net loss for Q2 2026 was €7.1 million, with EPS at -€0.21.
Adjusted EBITDA margin improved to 5.4–5.5% in Q2 2026.
Gross profit fell 7% to €50.0 million in H1 2026.
Outlook and guidance
2026 net revenue expected between -10% and 0% year-over-year, with adjusted EBITDA margin forecasted between breakeven and mid-single digits.
Year-end cash projected at €25–30 million.
Average order value expected to rise, supported by premium lens expansion and Switch subscription growth.
Ongoing geopolitical risks and higher working capital/non-recurring cash outflows expected.
Latest events from Mister Spex
- Q1 2026 saw earnings and margin gains, led by offline growth and strategic shifts, despite revenue decline.MRX
Q1 2026 - Margin expansion and profitability inflection achieved, with EBIT loss reduced by €59m.MRX
Q4 2025 - Q3 2025 revenue fell 18%, but gross margin and EBIT improved sharply amid ongoing transformation.MRX
Q3 2025 - Gross margin rose to 55.0% as cost discipline offset revenue declines and losses narrowed.MRX
Q2 2025 - Gross margin rose to 48.8% as restructuring drove losses and international sales fell 17%.MRX
Q3 2024 - Profitability challenges prompt transformation and rebranding amid modest revenue growth.MRX
H1 2024 - Gross margin rose to 56.4% and EBIT loss narrowed, despite a 13% revenue drop.MRX
Q1 2025 - Restructuring led to a 3% revenue drop and wider losses in 2024; EBIT to improve in 2025.MRX
H2 2024